Literature DB >> 26701662

Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance Regulator.

Erika Nieddu1, Benedetta Pollarolo1, Marco T Mazzei1, Maria Anzaldi1, Silvia Schenone1, Nicoletta Pedemonte2, Luis J V Galietta2, Mauro Mazzei1.   

Abstract

The phenylhydrazone RDR-1 is endowed with moderate activity as F508del-CFTR corrector; nevertheless, its simple structure enables stimulating developments in this class of correctors. Therefore, we synthesized a number of phenylhydrazones 3 by reacting phenylhydrazine derivatives 1 with furfural derivatives 2. By the same reaction, also the pyridine derivatives 4, the thiophene derivatives 5, and the hydrazides 6 and 7 were prepared. All compounds were tested as F508del-CFTR correctors in the cystic fibrosis (CF) bronchial epithelial cell line CFBE41o-, using corr-4a and VX-809 as controls. Some of the tested compounds emerged as interesting F508del-CFTR correctors at 20 μM (3c) and 2 μM (5d). 3c and 5d administered together with VX-809 produced a satisfactory additivity of action. When the structure of 5d was overlapped with RDR-1 and five other established correctors, a shared central design was clearly visible. This fact may be of interest in the search for new F508del-CFTR correctors.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CFTR; Correctors; Cystic fibrosis; Ion channels; Phenylhydrazones

Mesh:

Substances:

Year:  2015        PMID: 26701662     DOI: 10.1002/ardp.201500352

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

Review 1.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

2.  Assessing cell-specific effects of genetic variations using tRNA microarrays.

Authors:  Christine Polte; Daniel Wedemeyer; Kathryn E Oliver; Johannes Wagner; Marcel J C Bijvelds; John Mahoney; Hugo R de Jonge; Eric J Sorscher; Zoya Ignatova
Journal:  BMC Genomics       Date:  2019-07-16       Impact factor: 3.969

3.  Synthesis and Biological Evaluation of Dantrolene-Like Hydrazide and Hydrazone Analogues as Multitarget Agents for Neurodegenerative Diseases.

Authors:  Isabella Bolognino; Nicola Giangregorio; Annamaria Tonazzi; Antón L Martínez; Cosimo D Altomare; María I Loza; Sara Sablone; Saverio Cellamare; Marco Catto
Journal:  ChemMedChem       Date:  2021-06-22       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.